Engaging Innovation | Friends of Cancer Research

Engaging Innovation

Featured Post

January 23, 2018

A Plea to Make Cancer Clinical Trials More Patient Friendly

Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To...
More Posts

Recent Posts

No Results With Current Filter Choices

TMB Harmonization Working Group Meeting

On May 10, 2018, Friends of Cancer Research (Friends) convened stakeholders across all health sectors to assess current methods of measuring tumor mutational burden (TMB) and develop a consensus approach to the standardization of this biomarker. This roundtable built on a workshop hosted by Friends in the Fall of 2017,...

Safeguarding the Public Health: Enhancing Information About Prescription Drugs

Friends of Cancer Research Congressional BriefingSafeguarding the Public Health: Enhancing Information About Prescription Drugs Patients and their caregivers need access to high quality information about the prescription drugs they use. While many sources of information exist, none can deliver as strong assurances of reliability and scientific rigor as FDA-approved product labels....

Molecularly Targeted Therapies in Pediatric Cancer

Robust drug development for pediatric cancers is critical to ensuring appropriate access to life-saving drugs and promoting innovation. As such, the FDA Reauthorization Act (FDARA) of 2017 included a provision requiring sponsors to investigate new molecularly targeted cancer drugs and biologics that are determined to be substantially relevant to the...

Biopharma Congress III

November 14, 2017Disruption In BiopharmaThe Ritz-Carlton, Washington D.C.1150 22nd Street, NW On Tuesday, November 14, 2017, Friends of Cancer Research (Friends) and Prevision Policy hosted the third annual BioPharma Congress. This year’s event focused on disruption in biopharma and featured speakers such as former FDA Commissioner Dr. Mark McClellan and former...

Friends of Cancer Research Annual Meeting 2017

Panel 1 Whitepaper - Panel 1 Slides Panel 2 Whitepaper - Panel 2 Slides Panel 3 Whitepaper - Panel 3 Slides   This year’s Friends Annual Meeting took place on November 15, 2017. The event began with a keynote by FDA Commissioner Dr. Scott Gottlieb. During his remarks, Dr. Gottlieb reiterated previous commitments for...

A Blueprint for Breakthrough – Charting the Course for Precision Medicine

Friends of Cancer Research with Alexandria Real Estate Equities, Inc. Co-Host: A Blueprint for Breakthrough – Charting the Course for Precision Medicine Click HERE to access the finalized meeting whitepaper. On Wednesday, September 13, 2017, Friends of Cancer Research (Friends) with Alexandria Real Estate Equities Inc. co-hosted the 6th annual Blueprint for...

21st Annual Cancer Leadership Awards Reception

October 4, 2017The Hay-Adams800 16th St NW, Washington, DC 20006 On October 4, 2017, Friends of Cancer Research (Friends) hosted the 21st Annual Cancer Leadership Awards Reception. The yearly event brings together leaders in government, advocacy, industry, and science to celebrate partnerships and innovations that benefit patients.   To mark the five-year anniversary...
first
prev
1
2
3
4
5
next
last
Back to Top